Business · 30/04/2015Updated: 10/17/2026 · 1 min read

FDA Releases Guidance on Biosimilars Implementation of the Biologics Price Competition and Innovation Act of 2009

The FDA has released a guidance document to address questions and concerns from industry stakeholders regarding the implementation of the Biologics Price Competition and Innovation Act of 2009, a law aimed at promoting competition and innovation in the biologics market.